Author:
Pérez-Barrón Gabriela,Ávila-Acevedo José Guillermo,García-Bores Ana María,Montes Sergio,García-Jiménez Sara,León-Rivera Ismael,Rubio-Osornio Moisés,Monroy-Noyola Antonio
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Toulouse A, Sullivan A (2008) Progress in Parkinson’s disease—where do we stand? Prog Neurobiol 85:376–392
2. Giroux ML (2007) Parkinson disease: managing a complex, progressive disease at all stages. Cleve Clin J Med 74:313–328
3. Agid Y, Javoy-Agid F, Ruberg M (1987) Biochemistry of neurotransmitters in Parkinson’s disease. In: Marsden CE, Fahn S (eds) Movements disorders. Butterworth, London, pp 166–230
4. Blum D, Torch S, Lambeng N, Nissou M, Benabid A, Sadoul R, Jean-Marc V (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog Neurobiol 65:135–172
5. Boll MC, Alcaraz-Zubeldia M, Ríos C (2011) Medical management of Parkinson’s disease: focus on neuroprotection. Curr Neuropharmacol 192:350–359
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献